EUVIMEDEUVIMED entdecken
Leserbrief

Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone

Ricardo D Parrondo iD, Ricardo C B de Menezes, Hanna Sledge, Madhavi Nayyar, Kanika Yadav, Leif Bergsagel, Rafael Fonseca, Prashant Kapoor, Francis Buadi, Morie A Gertz iD, Angela Dispenzieri iD, Vivek Roy und 8 weitere

American Journal of Hematology · 2026-04 · 101 (4) · 884-888

DOI: 10.1002/ajh.70258 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 25.02.2026. Verfasst von Ricardo D Parrondo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Department of Hematology, Hospital Moinhos de Vento, Porto Alegre, Brazil.
  • Division of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA.
  • Division of Hematology-Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Ricardo D Parrondo, Morie A Gertz, Angela Dispenzieri, Joselle Cook, Shaji Kumar

Zitieren

APA

Parrondo, R. D., de Menezes, R. C. B., Sledge, H., Nayyar, M., Yadav, K., Bergsagel, L., Fonseca, R., Kapoor, P., Buadi, F., Gertz, M. A., Dispenzieri, A., Roy, V., Abdallah, N., Chhabra, S., Rajkumar, S. V., Gonsalves, W. I., Cook, J., Kumar, S., Chanan-Khan, A. A., & Ailawadhi, S. (2026). Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone. American Journal of Hematology, 101(4), 884-888. https://doi.org/10.1002/ajh.70258

Vancouver

Parrondo RD, de Menezes RCB, Sledge H, Nayyar M, Yadav K, Bergsagel L, et al. Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone. American Journal of Hematology. 2026;101(4):884-888. doi:10.1002/ajh.70258

BibTeX
@article{Parrondo2026,
  author = {Parrondo, Ricardo D and de Menezes, Ricardo C B and Sledge, Hanna and Nayyar, Madhavi and Yadav, Kanika and Bergsagel, Leif and Fonseca, Rafael and Kapoor, Prashant and Buadi, Francis and Gertz, Morie A and Dispenzieri, Angela and Roy, Vivek and Abdallah, Nadine and Chhabra, Saurabh and Rajkumar, S Vincent and Gonsalves, Wilson I and Cook, Joselle and Kumar, Shaji and Chanan-Khan, Asher A and Ailawadhi, Sikander},
  title = {Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front‐Line Daratumumab Lenalidomide and Dexamethasone},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {4},
  pages = {884--888},
  doi = {10.1002/ajh.70258}
}
Kostenlos starten →